Adaptive Biotechnologies Corp (ADPT) stock news · rev $142.4M
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
This ADPT news page leads with what Adaptive Biotechnologies Corp filed — not a scraped headline mill.
No cached 8-K sentence for ADPT yet. We will not pad this page with generic market recap.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADPT stock page; for the tape open the quote page.
Not investment advice.